Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sadelain

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Methods in Molecular Medicine|February 5, 2014
Methods for retrovirus-mediated gene transfer into primary T-lymphocytesM Sadelain
Methods in Molecular Medicine|February 5, 2014
Methods for the construction of retroviral vectors and the generation of high-titer producersI Rivière, M Sadelain
Seminars in Hematology|June 13, 1998
Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencingS Rivella, M Sadelain
Immuno-Oncology Technology|June 27, 2022
Function and evolution of the prototypic CD28ζ and 4-1BBζ chimeric antigen receptorsJ Feucht, M Sadelain
Trends in Cardiovascular Medicine|November 16, 2001
A promising genetic approach to the treatment of beta-thalassemiaC May, M Sadelain
Seminars in Hematology|October 18, 2001
Toward gene therapy for disorders of globin synthesisJ Tisdale, M Sadelain
Nature Biotechnology|April 5, 2000
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cellsJ B Latouche, M Sadelain
Current Opinion in Hematology|October 31, 2000
Issues in the manufacture and transplantation of genetically modified hematopoietic stem cellsM Sadelain, F Frassoni, I Rivière
Gene Therapy|February 12, 1998
The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytesH F Gallardo, C Tan, M Sadelain
Critical Reviews in Immunology|October 20, 2001
A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?J Tasch, M Gong, M Sadelain, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Methods in Molecular Medicine|February 5, 2014
Methods for retrovirus-mediated gene transfer into primary T-lymphocytesM Sadelain
Methods in Molecular Medicine|February 5, 2014
Methods for the construction of retroviral vectors and the generation of high-titer producersI Rivière, M Sadelain
Seminars in Hematology|June 13, 1998
Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencingS Rivella, M Sadelain
Immuno-Oncology Technology|June 27, 2022
Function and evolution of the prototypic CD28ζ and 4-1BBζ chimeric antigen receptorsJ Feucht, M Sadelain
Trends in Cardiovascular Medicine|November 16, 2001
A promising genetic approach to the treatment of beta-thalassemiaC May, M Sadelain
Seminars in Hematology|October 18, 2001
Toward gene therapy for disorders of globin synthesisJ Tisdale, M Sadelain
Nature Biotechnology|April 5, 2000
Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cellsJ B Latouche, M Sadelain
Current Opinion in Hematology|October 31, 2000
Issues in the manufacture and transplantation of genetically modified hematopoietic stem cellsM Sadelain, F Frassoni, I Rivière
Gene Therapy|February 12, 1998
The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytesH F Gallardo, C Tan, M Sadelain
Critical Reviews in Immunology|October 20, 2001
A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?J Tasch, M Gong, M Sadelain, et al.
Pageof 5